Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

The increasing drive to understand the likelihood of skin sensitisation from plant protection products (PPPs) in workers and the general public has resulted in recent initiatives to establish a quantitative risk assessment (QRA) methodology applicable to these products and their exposure scenarios. The effective evaluation of skin sensitising substances requires not only the identification of that toxicological hazard, but also determination of relative sensitising potency. Typically, this has been achieved by interpretation of local lymph node assay (LLNA) dose response data, delivering what is known as the EC3 value. This permitted regulatory division of skin sensitisers into defined potency sub-categories, but more importantly enabled derivation of a no expected sensitisation induction level (NESIL) as the point of departure for QRA. However, for many existing substances there is no LLNA data, only older guinea pig results exist. To avoid additional (in vivo) testing, an approach has been outlined to employ guinea pig data and existing regulatory guidelines on the determination of potency sub-categorisation to provide a guinea pig based NESIL. The approach adopts a conservative extrapolation from LLNA NESIL benchmarks to deliver points of departure as the basis for the type of QRA process already in successful use by other industries. Copyright © 2024 Elsevier Inc. All rights reserved.

Citation

David Basketter, Namali Corea, Marco Corvaro, Arthur Grivel, Felix M Kluxen, Neil Morgan, Christiane Wiemann. Use of guinea pig data to obtain starting points for skin sensitisation risk assessment - A commentary. Regulatory toxicology and pharmacology : RTP. 2024 Mar;148:105584

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 38417477

View Full Text